MARY BENARD: Open Payments
NPI 1962861864 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 46 payments from 15 companies in 2025. Trend: 2023 $143 · 2024 $719 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $180 |
| Novo Nordisk Inc | 4 | $91 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Lundbeck LLC | 5 | $87 |
| Phathom Pharmaceuticals, Inc. | 5 | $76 |
| PFIZER INC. | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $40 |
Products named: REXULTI, BREZTRI, VOQUEZNA, JARDIANCE, TRELEGY ELLIPTA, FARXIGA, AIRSUPRA, Rybelsus.
Industry payments across TX — which companies pay providers there.
